Press release content from Business Wire. The AP news staff was not involved in its creation.
Related topics

Sage Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023

PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.
January 3, 2023 GMT

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 3, 2023--

Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 10:30 a.m. PT in San Francisco, CA.

A live webcast of the presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit. www.sagerx.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20230103005159/en/

CONTACT: Investors

Helen Rubinstein

315-382-3979

helen.rubinstein@sagerx.comMedia

Matthew Henson

917-930-7147

matthew.henson@sagerx.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: HEALTH NEUROLOGY OTHER HEALTH GENERAL HEALTH PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Sage Therapeutics, Inc.

Copyright Business Wire 2023.

PUB: 01/03/2023 06:30 AM/DISC: 01/03/2023 06:30 AM

http://www.businesswire.com/news/home/20230103005159/en